Legal-legal basis of improvement of continuing education staff enterprises industrial pharmacy P a r t II List of positions subject to certification, licensing and certification of personnel of the enterprises for the production of medicines
Abstract
The aim of the work was the creation , development and approval of the draft resolution of the Cabinet of Ministers of Ukraine and the Regulations on the licensing, certification of enterprises for the production of medicines.
Studies were conducted on the basis of a retrospective analysis methods of the current state of postgraduate education staff training, retraining and certification pharma companies .
Good manufacturing practice requirements , combine to provide a system efficiency of drugs in outstanding quality depends on the human capacity. System of product quality, the appropriate level of staff should be fully documented and its effectiveness - controlled. Thus, all components of the system, its subsystems, components should properly be provided by qualified personnel. Each employee should clearly understand individual responsibility , which should be documented . Level of professional competence should be subordinate appropriate certificate universities III–IV accreditation levels .
In Ukraine there is still such criteria are not normalized to the staff . The proposed draft resolution of the Cabinet of Ministers of Ukraine regarding the Regulation on licensing and certification training companies Industrial Pharmacy provides a basis to eliminate obstacles to the implementation of the constitutional right to post-graduate education and improvement of personnel of the enterprises of the pharmaceutical industry .
The list of positions subject to certification, licensing and certification of personnel companies producing drugs is part and goals, objectives and content of the basic provisions in the body (part I).
References
2. Volkov SV, Kovalchuk S.P., Genko V. M., Reshetnyak O. V. Nanochemistry. Nanosystems Nanomaterials - K .: Science. opinion, 2008. - 422 pp.
3. Gritsenko O. M., Ponomarenko MS, Babsky AA and others. Ethical declaration of the behavior of specialists in the field of creation, production, circulation, promotion and advertising of medicinal products (pharmacies, drugstores). - K.: Print Quic, 2007. - 12 p.
4. Zagory VA Complex program-target management of production of medicines in the conditions of implementation of GMP rules in the pharmaceutical enterprise: Dis. ... Dr. farm. Sciences: 15.00.01. - Kharkiv, 2002. -361 p.
5. Zaporozhan VN The Way to Nooetics. - Odessa: Odessa. state honey. Unt., 2008. - 284 pp.
6. Classifier of professions DK 003: 2010 / SD NDI social-labor. relations of labor and social. policy of Ukraine; in-t ukr the languages of the National Academy of Sciences of Ukraine; State Statistics Committee of Ukraine. - K .: Sotsinform, 2010. - 745 p.
7. Movchan B. A. Electron-beam hybrid nanotechnology of depositing inorganic materials in vacuum / Act. probl sovr material science. - K.: Academiperiodika, 2008. - Vol. 1. - P. 227 - 247.
8. Proper medical practice of medicine / Ed. N. A. Lyapunov, V. Zagoria, V. P. Georgievskii and others - K.: Morion, 1999. - P. 52-60.
9. Paliy V. Astrologer and fortune teller in law, or do we need such a classification of professions? // Bull VAC of Ukraine. - 2010. - No. 11. - P. 36-38.
10. Paton B. E., Moskalenko V. F., Chekman I. S., Movchan B. O. Nanoscience and Nanotechnology: Technical, Medical and Social Aspects // Vysn. National Academy of Sciences of Ukraine. - 2009. - No. 6. - P. 76-80.
11. Ponomarenko MS, Zagory GV, Babsky AA and others. Noofarmatichesky, scientific and practical substantiation for the creation of qualification characteristics of employees of the newly created positions in the Ukrainian labor market from the emergent and poetic positions. Noofarmatsiya // Odessa. honey. journ - 2011. - No. 3. - P. 15-20.
12. Ponomarenko MS, Solovyov O.S., Kirpach O. V. and others. Noofarmacy, Pharmacoeconomics in Science, Education, Practice / Management and Marketing in the Contemporary Economy, Science, Education, Practice: Mater. intern science-practice internet conf. (Kharkiv), March 28-29, 2013 / Ed. Z. Mnushko and others. - Kharkiv: View of the NFUU, 2013. - P. 366-367.
13. Storozhuk Y. Ban can not be advertised // Recipes of pharmacy sales. - 2012. - No. 3. - P. 14-15.
14. Trakhtenberg I. M., Ulberg Z. R., Chekman I. S. Nanoscience: terminological and substantive aspects // The art of treatment. - 2013. - № 7. - S. 42-44.
15. Chekman I.S., Simonov P.V. Natural Nanostructures and Nanomechanisms. - K.: The Other, 2012. - 104 p.
16. Chekman I. S. Nanopharmacology. - K: A friend. 2011. - 424 pp.
17. Chekman I. S. Ulbert Z.R., Malaychuk V.O. etc. Nanoscience, nanobiology, nanofarmation. - K.: Polygraph plus, 2012. - 328 p.
18. Allhoff F., Lin P. What's So Special About Nanotechnology and Nanjethics? // Int. J. Appl. Phil - 2008. - V. 20, N 2. - P. 179-190.
19. Ashai Z. A., Pukhta MA, Abbas Z. et al. Nanopharmecology // JK-Practitioner. - 2012. - V. 17, N 1-3. - P. 83-85.
20. Good manufacturing practices for pharmaceutical products // WHO Expert Committee on Specifics for Pharmaceutical Preparations: Thirty-second Report. - Geneva: World Health Organization, 1992 (WHO Technical Report Series, No. 823). - P. 14-79.
21. European Pharmacopea, Suppl. - 4 ed. Council of Europe - Strasbourg: EDQM, 2001 - 2415 p.
22. USP Pharmacists' Pharmacopea - 2 nd ed. - Rockville: The United State Pharmacopea, Inc., 2008 - 1519 p.
23. Medina C., Santos-Martinez M. J., Radomski A. et al. Nanoparticles pharmacological and toxicological significance // Br. J. Pharmacol. - 2007. - P. 150. - P. 552-558.
24. Megawati O. Nanopharmacy - opportunities and prospects: a perspective from the Nanopharmacy Research Laboratory. - Access mode: http: //www.researchsea.com/html/article.php/aid/5269/cid/1/reseach/nanopharmacy_possiblities_and_prospects_aperspective_from_nanopharmacy_research_laboratory.html?PHPSESSID=7ha650chdip7cvoshqi9recq2
25. Kawasaki E. S., Player A. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer // Nanomedicine. - 2005 - V. 1, N 2. - P. 101-109.
26. Rivera G. P., Huhn D., de Mercato L. L. et al. Nanopharmacy: inorganic nanoscale devices as vectors and active compounds // Pharmacol. Res - 2010. - V. 62, N 2. - P. 115-125.
27. The National Committee for Nano-Engineering. [Electronic resource]. - Access mode: http: //www.engineersausralia.org.aul.nano-engineering/wthat-nano-engineering
28. Varshney H. M., Shailender M. "Nanotechnology" current status in the medical sciences: a review // Int. J. Ther. Appl. - 2012. - V. 6. - P. 14-24.
This work is licensed under a Creative Commons Attribution 4.0 International License.
